Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidKent Shih
    Ask Trek AI about this page

    Kent Shih — Billing Profile & Reimbursement Data

    NPI 1619075207 · Nashville, TN · Hematology & Oncology Physician

    Customize your policy alerts

    Sign up for Kent Shih — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Kent Shih is a hematology & oncology physician provider located in Nashville, Tennessee. This profile covers 61 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationKent Shih
    Address4220 Harding Pike
    CityNashville
    StateTN
    ZIP37205
    TaxonomyHematology & Oncology Physician
    NPI EnumeratedSeptember 20, 2006

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$2.2M
    Medicaid$0

    Key Findings

    Provider is heavily Medicare-focused with $2.2M in lifetime Medicare revenue and no Medicaid billing on file (none), making this effectively a single-payer Medicare practice; this payer concentration means analyses of utilization and risk should be centered on Medicare claims patterns rather than a dual-payer mix.

    Revenue is highly concentrated in a small set of biologic immunotherapy and targeted infusion codes: the top 3 Medicare codes account for 79.1% of this provider's Medicare revenue, driven largely by J9271, J9299, and Q5107, indicating a practice model organized around high-volume oncology infusions rather than procedural or ancillary service lines.

    J9271 (pembrolizumab) is the clear revenue driver with $1.2M (57.5% of this provider's total Medicare revenue) from 28.6K claims and ranks #142 of 1841 nationally (92th percentile; typical, unremarkable volume for this code), signaling a strong national presence on this specific checkpoint inhibitor even as the dataset labels the volume as within expected ranges.

    J9299 (nivolumab) contributes $366.7K (17.1% of this provider's total Medicare revenue) from 15.3K claims and ranks #240 of 505 (53th percentile; typical, unremarkable volume for this code), which positions the provider as a modest participant for this alternative PD-1 therapy compared with peers.

    Q5107 (bevacizumab-awwb, mvasi biosimilar) adds $97.3K (4.5% of this provider's total Medicare revenue) from 4.2K claims and ranks #19 of 78 (77th percentile; typical, unremarkable volume for this code), indicating above-average use of this biosimilar among the smaller national cohort that bills it.

    The visit and administration mix supports an office-based oncology infusion model: high-volume chemotherapy/infusion codes such as 96413 (505 claims, $46K revenue), 96365 (75 claims, $3.3K), and add-on 96417 (163 claims, $7.3K) appear alongside infusion biologic codes, while lab panels (80053, 85025) and supportive medications (J0897 denosumab, J0881 darbepoetin alfa, J1439 ferric carboxymaltose) reflect comprehensive outpatient oncology management.

    Practice coding shows notable statistical outliers: 99215 has 770 claims for $96.3K and ranks #609 of 145531 (100th percentile; extreme outlier, far above typical national volume for this code), which suggests unusually high volume of high-complexity E/M visits relative to national peers and should be investigated as a distinguishing operational feature.

    Operational participation in value/payment models is evident: M0010 (EOM monthly enhanced oncology services) appears with 168 claims and $11.6K revenue, ranking #110 of 544 (80th percentile; typical, unremarkable volume for this code), indicating the provider is engaged with enhanced oncology service payments at a higher-than-median level among EOM participants.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    61 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J9271Injection, pembrolizumab, 1 mg28,600$40$1.2M
    J9299Injection, nivolumab, 1 mg15,280$20$366.7K
    Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg4,230$20$97.3K
    99215The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…770$130$96.3K
    J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg170$350$59.3K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…510$90$46K
    J0897Injection, denosumab, 1 mg1,980$20$35.6K
    J1439Injection, ferric carboxymaltose, 1 mg32,250$1$32.3K
    J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)15,590$1$31.2K
    99214The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…200$90$18.4K

    Showing 1–10 of 61

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 61 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    61 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J927175017,400$40$776.1K
    J9299132021,010$20$487.5K
    J08971562402,940$20$85K
    Q51073202,990$20$77.6K
    J0881507019,050$1$54.4K
    J1439519034,130$1$38.6K
    J145417070$340$25.6K
    9641326240150$90$18.9K
    992144,03611,370120$80$16.6K
    992331,5922,63090$90$13.1K

    Showing 1–10 of 61

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Kent Shih, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Tennessee Oncology PLLCTNHematology & Oncology Physician$0$8.5M
    James GrayTNRadiation Oncology Physician$4.9M$0
    Mark WomackTNHematology & Oncology Physician$2.4M$0
    Bertrand AnzTNHematology & Oncology Physician$2.4M$0
    Dana ThompsonTNMedical Oncology Physician$2.2M$0
    Joshua MondscheinTNRadiation Oncology Physician$2.1M$0
    Derek HollandTNHematology & Oncology Physician$2M$0
    Josiah MagnussonFLNuclear Medicine Physician$1.8M$0
    William DonnellanTNHematology & Oncology Physician$1.7M$0
    Clint KingsleyALHematology & Oncology Physician$1.6M$22K

    Nearby Providers

    Other providers in the same ZIP code as Kent Shih, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Old Harding Pediatric AssociatesTNPediatrics Physician$0$7.3M
    Saint Thomas West HospitalTNGeneral Acute Care Hospital$0$7.1M
    Adams & Seaton Pediatric DentistryTNPediatric Dentistry$0$3.7M
    Saint Thomas Campus Surgicare LPTNAmbulatory Surgical Clinic/Center$1.3M$0
    Elizabeth LyonsTNRheumatology Physician$1.2M$0
    Colt McclainTNAnatomic Pathology & Clinical Pathology Physician$962.9K$0
    Imaging Alliance Nashville Pet LLCTNRadiology Clinic/Center$456.7K$255.5K
    Gregg ShepardTNHematology & Oncology Physician$653K$0
    Heikki KostamaaTNRetina Specialist (Ophthalmology) Physician$608K$0
    Middle Tennessee Imaging LLCTNPortable X-ray and/or Other Portable Diagnostic Imaging Supplier$506.4K$10.1K

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Tennessee Distribution
    Kent Shih — 5 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Tennessee